The effect of oral administration of thyme honey on anemia and some cardiovascular risk factors in hemodialysis patients
Not Applicable
Recruiting
- Conditions
- Hemodialysis.Chronic kidney disease, stage 5
- Registration Number
- IRCT201705266318N9
- Lead Sponsor
- Vice chancellor for research, Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Desire to participate and giving the written consent; treatment with hemodialysis 3 times a week for 3 hours or more per session and for more than 3 months; not being diagnosed with cancer; mental disability; liver failure and not being allergic to honey. Exclusion criteria: Hospitalization and changes in the patient's medications during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin. Timepoint: Before the intervention; one month after intervention. Method of measurement: In this study, hemoglobin is measured with Cell take E.
- Secondary Outcome Measures
Name Time Method C- reactive protein. Timepoint: Before the intervention; one month after intervention. Method of measurement: In this study, C-Reactivate protein is measured with bionik vial.;Glucose. Timepoint: Before the intervention; one month after intervention. Method of measurement: In this study, glucose is measured with Pars test.;Hematocrit. Timepoint: Before the intervention; one month after intervention. Method of measurement: In this study, hematocrit is measured with Cell take E.;Lipids. Timepoint: Before the intervention; one month after intervention. Method of measurement: In this study, lipids are measured with Pars test.